Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells
about
CpG Oligonucleotides as Cancer Vaccine AdjuvantsHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerRegulation of tumor metastasis by myeloid-derived suppressor cellsAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationPhenotype, development, and biological function of myeloid-derived suppressor cellsDynamic Metabolism in Immune ResponseCirculating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia.Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection.Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotypeProtumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion.TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation.Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.Reactive oxygen species in the immune system.Myeloid-derived suppressor cells in cancer: recent progress and prospects.Metabolic control of tumour progression and antitumour immunitySignaling pathways involved in MDSC regulation.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1.Mechanisms regulating immune surveillance of cellular stress in cancer.Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype.Innate sensing of cancer's non-immunologic hallmarks.Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
P2860
Q26783826-5BDF9EC0-B304-4E23-8B4A-E2531DAE4AABQ26863418-A883E614-13EE-47CE-A163-77D02796CCADQ27022125-872193CC-5D38-42FC-9C74-EDCF2A893B14Q28074536-B764D47D-00B1-4DE2-A8D5-ACBF7C9DD201Q28079046-ABB49057-8352-4EDE-A25F-4D193EB25564Q28391962-45878924-BF69-49CC-B4B9-167391D5F590Q33439544-827ED778-DF1B-4CC6-9FF3-384A7E231227Q33754157-4E12A2DB-32EB-41BE-93C3-4ED3894EAD25Q35169807-608B8A2D-9E34-488E-8DA2-7027690592D3Q36110362-7A4857C6-E92A-475C-9052-5D6A72FB5C11Q36275124-5304AFD2-75A2-442C-A227-D389A43034F9Q36597484-2D0346BE-C5E6-4A2F-8237-62D9DA3BDE27Q36729107-6F77AB31-7AA8-433B-9031-67E6D1CDBE3BQ36809157-0D9F6140-DA39-4F87-BA7D-CA826D488809Q37494817-7B4A4E30-C7E3-4C5B-B81E-D3ACA45A4AE6Q38101671-87D9DE24-E2F7-4A62-8B21-D0E45E734C34Q38116711-19247657-8335-4721-AB7F-3BC29561924BQ38168678-D61A04EB-899A-4245-A1ED-35C225B63156Q38204175-269D415B-AF95-4EC6-AB2B-3F846946C9E8Q38299932-992E0172-881D-456B-93FB-49CF51E866C3Q38825933-93DBBF14-5F22-4B35-AD2E-C3EA6CA17036Q39458697-A84012F9-31F3-4AFD-8DCA-B7328B7952D6Q40229629-13BB8BB5-1352-4B9B-9B8D-04A7620BC1E2Q41709177-2DDDF110-845A-4686-8FD9-BBA3EE313325Q46065433-F889E622-D820-45DC-B545-833F2CD4AC3DQ50220559-8A4D2A39-EBFE-4F81-99F8-AF7047084D59
P2860
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@ast
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@en
type
label
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@ast
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@en
prefLabel
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@ast
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@en
P2093
P2860
P356
P1476
Myeloid-derived suppressor cel ...... s from CD4+CD25-FoxP3- T cells
@en
P2093
Claire B Larmonier
Collin J LaCasse
Darya Alizadeh
Emmanuel Katsanis
Jessica Kartchner
Malika Trad
Neale T Hanke
Nicolas Larmonier
Nona Janikashvili
Sara M Centuori
P2860
P304
P356
10.1189/JLB.0911465
P577
2012-08-13T00:00:00Z